Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version




Profile of registrant

International Drug Policy Consortium

Identification number in the register: 75318797051-52
Registration date: 01/11/11 17:02:21

The information on this organisation was last modified on 06/10/14 12:00:20
The date of the last annual update was 06/10/14 12:00:20


Registrant : Organisation or self-employed individual

Name/company name: International Drug Policy Consortium
Acronym: IDPC
Legal status: Company limited by guarantee
Website address: http://www.idpc.net

Sections

Section: III - Non-governmental organisations
and more precisely: Non-governmental organisations, platforms and networks and similar

Person with legal responsibility

Surname, Name: Ms  Ann Fordham
Position: Executive Director

Permanent person in charge of EU relations

Surname, Name: Mr  Mike Trace
Position: Chair

Contact details:

Contact details of organisation's head office: 124-128 City Road, 5th Floor 
London EC1V 2NJ
UNITED KINGDOM
Telephone number: (+44) 2073242975
Fax number: (+44) 2073242977
Other contact information: IDPC is a global network of NGOs and professional networks that come together to promote objective and open debate on drug policy issues at the national and international level. We support evidence-based policies that are effective in reducing drug-related harm.

IDPC’s vision is that national and international drug policies are grounded in the principles of human rights and human security, social inclusion, public health, development and civil society engagement.

IDPC intervenes at two levels in the decision making process: We facilitate networking and collaboration between civil society stakeholders, and seek to empower civil society and the most affected populations to better engage with and influence policy making processes. In parallel, IDPC also intervenes directly with high-level policy making processes by providing analysis and expertise to governments and UN agencies on effective and more humane drug policy options.

IDPC members promote the following policy principles in our advocacy work with national governments and international agencies:
1. Drug policies should be developed through a structured and objective assessment of priorities and evidence.
2. All activities should be undertaken in full compliance with international human rights law.
3. Drug policies should focus on reducing the harmful consequences rather than the scale of drug use and markets.
4. Policy and activities should seek to promote the social inclusion of marginalised groups, and not focus on punitive measures towards them.
5. Governments should build open and constructive relationships with civil society in the discussion and delivery of their strategies.

Goals / remit

Goals / remit of the organisation: IDPC is a a global network of NGOs and professional networks that come together to promote objective and open debate on drug policy issues at the national and international level. We support evidence-based policies that are effective in reducing drug-related harm.

IDPC produces briefing papers, disseminates the reports of its member organisations about particular drug-related matters, and offers expert advice to policy makers and officials around the world.

IDPC members have a wide range of experience and expertise in the analysis of drug problems and policies, and have contributed to policy debates at national and international level.

We have two main objectives:
- We provide channels for grassroots organisations to better engage with policy making processes: we facilitate communication and cooperation between civil society stakeholders, and we produce and disseminate information and materials on more effective and humane drug policies, that national and local NGOs can use in their own work. We also organise capacity building trainings to support the drug policy advocacy work of NGOs. In order to facilitate civil society engagement, we organise our work regionally.

- We draw on the knowledge within our network to offer expert advice to policy makers on how best to review their drug policies at the national and international level. The IDPC network includes many individuals who have experience of creating or reviewing government drug policies and strategies, and these individuals are available to engage in high-level discussions with policy makers.
The organisation's fields of interests are:
  • national
  • European
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 9
Complementary information: IDPC staff includes five full time and one part-time staff members. We also hire consultants around the world who work on thematic or regional issues related to drug policy. For more information on the IDPC team, please visit: www.idpc.net/team.

Persons accredited for access to European Parliament premises

No accredited persons

Activities

Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:


Over the past three years, under grants from the European Commission Drug Prevention and Information Programme, IDPC conducted a number of activities across Europe, in collaboration with key NGO partners.

In 2010-2011, IDPC supported the creation of a dynamic network of NGOs from South East Europe to promote exchange of information and experience among professionals in the field of drug policy in the region. We also produced a number of publications focused on South East Europe and Western European countries.

Since April 2011, IDPC has been involved in a project funded by the European Commission in collaboration with the Transnational Institute and other European NGOs. This project aims to promote exchange of experience through informal drug policy dialogues, expert seminars and the drafting of expert publications on issues related to the European Union and European countries.

IDPC also shares evidence and best practice from the EU and its member states in international forums, such as the Commission on Narcotic Drugs (CND), through the organisation of side events, the dissemination of materials and direct meetings with government delegations.

IDPC is also an active member of the European Commission Civil Society Forum on Drugs where we have engaged in drug policy debates regarding the European Union Drug Strategy and its Action Plans. Individually, IDPC has also watched closely the drafting of the new EU Drug Strategy for 2013-2020 and the Action Plan for 2013-2016. We has provided a set of recommendations, as well as organised a seminar at the European Parliament in May 2012 to ensure open discussions among representatives of EU institutions and international experts on the direction of EU drug policy for the coming years.

Today, IDPC is engaged in offering recommendations to the European Commission, in particular the Horizontal Drugs Group, on key aspects of European Drug Policy and strategic positions in the lead up to the United Nations General Assembly Special Session on Drugs (UNGASS) to be held in 2016.

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Communication
  • Development
  • External Relations
  • Home Affairs
  • Justice and Fundamental Rights
  • Public Health
  • Regional Policy
  • Trans-European Networks
  • Youth

Structure

Total number of members that are natural persons: 120
Number of member organisations:
Member organisations (Number of members) :
The organisation has members/is represented in the following country(countries):
  • BELGIUM
  • BULGARIA
  • CROATIA
  • DENMARK
  • FRANCE
  • GERMANY
  • GREECE
  • HUNGARY
  • IRELAND
  • ITALY
  • LITUANIA
  • NETHERLANDS
  • POLAND
  • PORTUGAL
  • ROMANIA
  • SLOVENIA
  • SPAIN
  • SWEDEN
  • UNITED KINGDOM

  • ALBANIA
  • ARGENTINA
  • AUSTRALIA
  • BOLIVIA
  • BOSNIA-HERZEGOVINA
  • BRAZIL
  • CANADA
  • CHILE
  • COLOMBIA
  • COSTA RICA
  • DOMINICAN REPUBLIC
  • EL SALVADOR
  • GEORGIA
  • INDIA
  • INDONESIA
  • KENYA
  • LEBANON
  • LIBERIA
  • MACEDONIA, FORMER YUGOSLAV REPUBLIC OF
  • MALAYSIA
  • MAURITIUS
  • MEXICO
  • MONTENEGRO
  • NEW ZEALAND
  • PALESTINIAN OCCUPIED TERRITORY
  • PERU
  • PUERTO RICO
  • RUSSIA, FEDERATION OF
  • SAINT LUCIA
  • SERBIA
  • SWITZERLAND
  • THAILAND
  • TUNISIA
  • TURKEY
  • UGANDA
  • UNITED ARAB EMIRATES
  • UNITED STATES
  • URUGUAY
  • VIETNAM
  • ZIMBABWE
Complementary information: The IDPC has two types of membership. Partner members work together to implement the annual IDPC work plan, while network members contribute to the dissemination of our ideas and materials. We come together to facilitate open debate on drug policy issues, and to promote more humane and effective policy at a national and international level.

For a full list of IDPC Partner Members, please visit: http://idpc.net/members/partners

For a full list of IDPC Network Members, please visit: http://idpc.net/members/network

For more information on IDPC's membership criteria, please visit: http://idpc.net/members/membership-criteria

Networking

Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.




IDPC is a member of the European Civil Society Forum on Drugs, and of the Vienna NGO Committee on Drugs. IDPC is now also a member of the New York NGO Committee on Drugs.

Financial data

Financial year: 04/2013 - 03/2014
Total budget: 963,781
of which public financing: 364,645
- from European sources:
- Procurement:
- Grants: 126,753
- from national sources: 237,892
- from local/regional sources:
from other sources: 599,136
- donations:
- contributions from members:
grants (OSF, RCNF, JP Getty, AIDS Alliance, Other foundations) : 599,136
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: 100000  € - 150000  €
Other (financial) information provided by the organisation:


Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.